To ascertain the modification sites for biochemical dissection of the functions of RPL10 ufmylation in pancreatic cancer cells, we overexpressed RPL10-K30R/K101R mutants to examine the changes of RPL10 ufmylation after the elimination of potential interferences from endogenous RPL10. Here, RPL10 is linked to pancreatic neoplasm.